We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGL icon
226
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.05B
$14M 0.11%
516,951
+35,897
+7% +$1.02M
AJG icon
227
Arthur J. Gallagher & Co
AJG
$64.5B
$13.7M 0.11%
84,261
-22,262
-21% -$3.69M
HSY icon
228
Hershey
HSY
$36.8B
$13.7M 0.11%
63,674
-20,055
-24% -$4.37M
TFC icon
229
Truist Financial
TFC
$64.2B
$13.6M 0.11%
287,422
-70,667
-20% -$3.49M
BAC icon
230
Bank of America
BAC
$441B
$13.6M 0.11%
437,265
-105,895
-19% -$3.81M
CI icon
231
Cigna
CI
$72.7B
$13.5M 0.11%
51,139
-12,551
-20% -$3.23M
KEY icon
232
KeyCorp
KEY
$24.3B
$13.5M 0.11%
781,496
+6,218
+0.8% +$120K
CSX icon
233
CSX Corp
CSX
$93.9B
$13.3M 0.11%
459,100
-64,142
-12% -$2.09M
PB icon
234
Prosperity Bancshares
PB
$8.88B
$13.1M 0.1%
191,249
+32,422
+20% +$2.23M
ETN icon
235
Eaton
ETN
$174B
$13M 0.1%
103,153
-56,070
-35% -$7.84M
DOC
236
DELISTED
PHYSICIANS REALTY TRUST
DOC
$13M 0.1%
742,621
-17,151
-2% -$303K
ACN icon
237
Accenture
ACN
$105B
$12.8M 0.1%
46,266
-27,073
-37% -$8.13M
EXPD icon
238
Expeditors International
EXPD
$23.2B
$12.7M 0.1%
130,494
-15,212
-10% -$1.56M
NUE icon
239
Nucor
NUE
$61.9B
$12.7M 0.1%
121,727
+864
+0.7% +$117K
TROW icon
240
T. Rowe Price
TROW
$24.2B
$12.7M 0.1%
111,378
-27,821
-20% -$3.54M
IGSB icon
241
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$12.6M 0.1%
250,045
+2,030
+0.8% +$103K
PFF icon
242
iShares Preferred and Income Securities ETF
PFF
$13.2B
$12.6M 0.1%
384,124
-80,188
-17% -$2.71M
DGX icon
243
Quest Diagnostics
DGX
$26.3B
$12.6M 0.1%
94,454
-15,295
-14% -$2.08M
WFC icon
244
Wells Fargo
WFC
$265B
$12.5M 0.1%
318,412
-75,463
-19% -$3.31M
LEG icon
245
Leggett & Platt
LEG
$1.31B
$12.3M 0.1%
354,772
-41,101
-10% -$1.51M
DXC icon
246
DXC Technology
DXC
$1.77B
$12.1M 0.1%
399,988
-91,239
-19% -$2.83M
KMB icon
247
Kimberly-Clark
KMB
$36.1B
$12.1M 0.1%
89,563
-17,056
-16% -$2.25M
EVRG icon
248
Evergy
EVRG
$19.1B
$12.1M 0.1%
185,328
-72,586
-28% -$4.92M
ATO icon
249
Atmos Energy
ATO
$28.7B
$12.1M 0.1%
107,770
-19,347
-15% -$2.22M
SGEN
250
DELISTED
Seagen Inc. Common Stock
SGEN
$12M 0.09%
67,881
-4,483
-6% -$646K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.